Who is sponsoring NCT05447052?

NCT05447052 is sponsored by University Hospital, Essen.

What drugs are being tested in NCT05447052?

Interventions in NCT05447052: Bio-MIMICS 3D Stent, Innova Stent.

What condition does NCT05447052 study?

NCT05447052 studies Peripheral Arterial Disease.

Is NCT05447052 still recruiting?

NCT05447052 is currently status unknown. Last updated 5 December 2023.

Last reviewed 2023-12-05 · How we verify

NCT05447052

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Biomimetic Stent and Vascular Functions Study

Status unknown NA Last updated 5 December 2023

What this trial tests

NA trial testing Bio-MIMICS 3D Stent in Peripheral Arterial Disease in 70 participants. Status unknown.

Timeline

26 April 2021

Primary endpoint
26 April 2024

26 April 2025

Quick facts

Lead sponsor	University Hospital, Essen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	70
Start date	26 April 2021
Primary completion	26 April 2024
Estimated completion	26 April 2025
Sites	1 location across Germany

Drugs / interventions tested

Bio-MIMICS 3D Stent
Innova Stent

Conditions studied

Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →

Sponsor

University Hospital, Essen

Who can join

Adults 18 to 85, any sex, with Peripheral Arterial Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this IIT is to determine the potential improvement and impact of the BioMimics 3D Stent System in the SFA on local vascular function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting

Other University Hospital, Essen trials

Trials by the same sponsor.

NCT07409584 — Mental Health and Suicidality in Glioblastoma Patients in Germany · recruiting
NCT07359690 — Multimodal Analysis of Endomyocardial Biopsies · recruiting
NCT06388369 — Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer · Phase 1, PHASE2 · terminated
NCT07130526 — Distrupt Stiffness Trial · NA · recruiting
NCT07343466 — Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device Implantation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05447052 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Essen
Last refreshed: 5 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05447052.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing